Literature DB >> 6253555

Short-term kinetics of serum adrenal steroids and plasma ACTH after a single dose of metyrapone in man.

M Schöneshöfer1, B Schefzig, S Arabin.   

Abstract

The in vivo influence of metyrapone (M) on different adrenal enzymes has been studied by simultaneous measurement of serum progesterone (P), 17-hydroxyprogesterone (17-OHP), deoxycorticosterone (DOC), corticosterone (B), deoxycortisol (S), 18-hydroxydeoxycorticosterone (18-OHDOC), aldosterone and cortisol (F) as well as by the measurement of plasma ACTH before and after oral administration of 40 mg of M/kg at 08:15 in four healthy male subjects. The well known inhibitory effect of M on adrenal 11-hydroxylase is demonstrated by a decrease of serum F and B and synchronous increase of serum S and DOC after administration of M. The additional inhibition of 18-hydroxylase by M is documented by a decrease of serum 18-OHDOC in spite of a marked increase of serum DOC after M. The moderate increase of serum P and 17-OHP soon after drug administration, although plasma ACTH is highly elevated at this time, as well as the marked increase of these steroids in the afternoon synchronously to a rise of serum F and B suggest a further inhibitory effect of M on the enzyme prior to the total corticosteroid biosynthesis. This effect of M should be taken into account if ACTH activity is monitored in terms of adrenal steroid output in the metyrapone test.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253555     DOI: 10.1007/BF03348268

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  35 in total

1.  Evaluation of 3 hour metyrapone test in children and adolescents.

Authors:  S Leisti
Journal:  Clin Endocrinol (Oxf)       Date:  1977-04       Impact factor: 3.478

2.  Simultaneous determinations of plasma ACTH and GH levels after an oral metyrapone.

Authors:  S Sawano; T Saito; K Shizume; K Takebe
Journal:  Endocrinol Jpn       Date:  1972-10

3.  Radioimmunoassay of ACTH in plasma.

Authors:  S A Berson; R S Yalow
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

4.  Extra-adrenal actions of metyrapone in man. Effects on plasma cortisol disappearance, growth hormone secretion and glucose metabolism.

Authors:  O D Bruno; R Leclerq; E Virasoro; G Copinschi
Journal:  J Clin Endocrinol Metab       Date:  1971-02       Impact factor: 5.958

5.  The metyrapone test of pituitary function.

Authors:  R P Doe; E M Gold
Journal:  Postgrad Med       Date:  1969-11       Impact factor: 3.840

6.  The interaction of metopirone with adrenal mitochondrial cytochrome P-450. A mechanism for the inhibition of adrenal steroid 11 beta-hydroxylation.

Authors:  D G Williamson; V J O'Donnell
Journal:  Biochemistry       Date:  1969-04       Impact factor: 3.162

7.  Inhibition of the biosynthesis of 18-hydroxy-11-deoxycorticos terone by SU-4885.

Authors:  I Kraulis; M K Birmingham
Journal:  Can J Biochem       Date:  1965-09

8.  Short time kinetics of deoxycorticosterone, deoxycortisol, corticosterone and cortisol during single dose metyrapone test.

Authors:  M Schöneshöfer; M L'age; W Oelkers
Journal:  Acta Endocrinol (Copenh)       Date:  1977-05

9.  A simplified metyrapone test with determination of plasma ll-deoxycortisol (Metyrapone test with plasma S).

Authors:  A W Meikle; W Jubiz; M P Hutchings; C D West; F H Tyler
Journal:  J Clin Endocrinol Metab       Date:  1969-07       Impact factor: 5.958

10.  Extraadrenal effects of metyrapone in man.

Authors:  J Levin; B Zumoff; D K Fukushima
Journal:  J Clin Endocrinol Metab       Date:  1978-10       Impact factor: 5.958

View more
  2 in total

1.  Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission.

Authors:  P V Piazza; M Barrot; F Rougé-Pont; M Marinelli; S Maccari; D N Abrous; H Simon; M Le Moal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

2.  11β-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis.

Authors:  Rafal M Kaminski; Michael A Rogawski
Journal:  Neuropharmacology       Date:  2011-03-31       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.